AIRLINK 212.00 Increased By ▲ 2.45 (1.17%)
BOP 10.55 Increased By ▲ 0.09 (0.86%)
CNERGY 7.42 Increased By ▲ 0.07 (0.95%)
FCCL 34.56 Increased By ▲ 0.17 (0.49%)
FFL 18.17 Increased By ▲ 0.12 (0.66%)
FLYNG 23.26 Increased By ▲ 0.34 (1.48%)
HUBC 131.99 Decreased By ▼ -0.50 (-0.38%)
HUMNL 14.28 Increased By ▲ 0.14 (0.99%)
KEL 5.10 Increased By ▲ 0.07 (1.39%)
KOSM 7.20 Increased By ▲ 0.13 (1.84%)
MLCF 45.33 Increased By ▲ 0.13 (0.29%)
OGDC 221.00 Increased By ▲ 2.62 (1.2%)
PACE 7.79 Increased By ▲ 0.21 (2.77%)
PAEL 42.49 Increased By ▲ 0.79 (1.89%)
PIAHCLA 17.52 Increased By ▲ 0.22 (1.27%)
PIBTL 8.75 Increased By ▲ 0.20 (2.34%)
POWERPS 12.50 No Change ▼ 0.00 (0%)
PPL 191.40 Increased By ▲ 2.37 (1.25%)
PRL 42.70 Increased By ▲ 0.37 (0.87%)
PTC 25.65 Increased By ▲ 0.48 (1.91%)
SEARL 104.50 Increased By ▲ 0.54 (0.52%)
SILK 1.03 No Change ▼ 0.00 (0%)
SSGC 41.15 Increased By ▲ 1.91 (4.87%)
SYM 19.44 Increased By ▲ 0.28 (1.46%)
TELE 9.43 Increased By ▲ 0.19 (2.06%)
TPLP 13.00 Decreased By ▼ -0.10 (-0.76%)
TRG 70.82 Increased By ▲ 1.64 (2.37%)
WAVESAPP 10.81 Increased By ▲ 0.09 (0.84%)
WTL 1.73 Increased By ▲ 0.02 (1.17%)
YOUW 4.18 Increased By ▲ 0.04 (0.97%)
BR100 12,229 Increased By 150 (1.24%)
BR30 37,008 Increased By 405.3 (1.11%)
KSE100 117,419 Increased By 1366.3 (1.18%)
KSE30 37,036 Increased By 458.5 (1.25%)

Pharmaceutical companies have refused to meet Minister of National Health Services Regulation and Coordination Saira Afzal Tarar, while the minister said that pharmaceutical companies can't blackmail the government. Negotiations between 11 pharmaceutical companies and the government could not be held. All companies except one (10 out of 11) have refused to talk with government.
While talking to media outside Parliament House, the minister said that the government called 11 companies for talks, in which only one group came, but others did not come. She said that she already approached the court.
She said that nine companies are manufacturing hepatitis medicine, while the government has introduced medicines at a low price, whereas the regulation did not mean to increase prices of medicines.

Copyright Business Recorder, 2016

Comments

Comments are closed.